Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Feb;70(2):1041–1049. doi: 10.1128/jvi.70.2.1041-1049.1996

Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells.

D E Schultz 1, M Honda 1, L E Whetter 1, K L McKnight 1, S M Lemon 1
PMCID: PMC189910  PMID: 8551562

Abstract

Mutations in the 5' nontranslated RNA (5'NTR) of an attenuated, cell culture-adapted hepatitis A virus (HAV), HM175/P16, enhance growth in cultured African green monkey kidney (BS-C-1) cells but not in fetal rhesus monkey kidney (FRhK-4) cells (S. P. Day, P. Murphy, E. A. Brown, and S. M. Lemon, J. Virol. 66: 6533-6540, 1992). To determine whether these mutations enhance cap-independent translation directed by the HAV internal ribosomal entry site (IRES), we compared the translational activities of the 5'NTRs of wild-type and HM175/P16 viruses in two stably transformed cell lines (BT7-H and FRhK-T7) which constitutively express cytoplasmic bacteriophage T7 RNA polymerase and which are derived from BS-C-1 and FRhK-4 cells, respectively. Translational activity was assessed by monitoring expression of a reporter protein, chloramphenicol acetyltransferase (CAT), following transfection with plasmid DNAs containing bicistronic T7 transcriptional units of the form luciferase-5'NTR-CAT. In both cell types, transcripts containing the 5'NTR of HM175/P16 expressed CAT at levels that were 50- to 100-fold lower than transcripts containing the IRES elements of Sabin type 1 poliovirus or encephalomyocarditis virus, confirming the low activity of the HAV IRES. However, in BT7-H cells, transcripts containing the 5'NTR of wild-type virus. This translational enhancement was due to additive effects of a UU deletion at nucleotides 203 and 204 and a U-to-G substitution at nucleotide 687 of HM175/P16. These mutations did not enhance translation in FRhK-T7 or Huh-T7 cells (a T7 polymerase-expressing cell line derived from human hepatoblastoma cells) or in vitro in rabbit reticulocyte lysates. These results demonstrate that mutations in the 5'NTR of a cell culture-adapted HAV enhance viral replication by facilitating cap-independent translation in a cell-type-specific fashion and support the concept that picornaviral host range is determined in part by differences in cellular translation initiation factors.

Full Text

The Full Text of this article is available as a PDF (273.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andino R., Rieckhof G. E., Baltimore D. A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell. 1990 Oct 19;63(2):369–380. doi: 10.1016/0092-8674(90)90170-j. [DOI] [PubMed] [Google Scholar]
  2. Borman A. M., Deliat F. G., Kean K. M. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J. 1994 Jul 1;13(13):3149–3157. doi: 10.1002/j.1460-2075.1994.tb06613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borman A., Howell M. T., Patton J. G., Jackson R. J. The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation. J Gen Virol. 1993 Sep;74(Pt 9):1775–1788. doi: 10.1099/0022-1317-74-9-1775. [DOI] [PubMed] [Google Scholar]
  4. Borovjagin A., Pestova T., Shatsky I. Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virus RNA translation at the level of preinitiation complex formation. FEBS Lett. 1994 Sep 12;351(3):299–302. doi: 10.1016/0014-5793(94)00848-5. [DOI] [PubMed] [Google Scholar]
  5. Brown E. A., Day S. P., Jansen R. W., Lemon S. M. The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol. 1991 Nov;65(11):5828–5838. doi: 10.1128/jvi.65.11.5828-5838.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown E. A., Zajac A. J., Lemon S. M. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J Virol. 1994 Feb;68(2):1066–1074. doi: 10.1128/jvi.68.2.1066-1074.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chang K. H., Brown E. A., Lemon S. M. Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol. 1993 Nov;67(11):6716–6725. doi: 10.1128/jvi.67.11.6716-6725.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cohen J. I., Rosenblum B., Ticehurst J. R., Daemer R. J., Feinstone S. M., Purcell R. H. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2497–2501. doi: 10.1073/pnas.84.8.2497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Day S. P., Murphy P., Brown E. A., Lemon S. M. Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol. 1992 Nov;66(11):6533–6540. doi: 10.1128/jvi.66.11.6533-6540.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Duke G. M., Hoffman M. A., Palmenberg A. C. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol. 1992 Mar;66(3):1602–1609. doi: 10.1128/jvi.66.3.1602-1609.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elroy-Stein O., Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6743–6747. doi: 10.1073/pnas.87.17.6743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Emerson S. U., Huang Y. K., McRill C., Lewis M., Purcell R. H. Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell culture. J Virol. 1992 Feb;66(2):650–654. doi: 10.1128/jvi.66.2.650-654.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Emerson S. U., Huang Y. K., Purcell R. H. 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology. 1993 Jun;194(2):475–480. doi: 10.1006/viro.1993.1286. [DOI] [PubMed] [Google Scholar]
  14. Freier S. M., Kierzek R., Jaeger J. A., Sugimoto N., Caruthers M. H., Neilson T., Turner D. H. Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9373–9377. doi: 10.1073/pnas.83.24.9373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fuerst T. R., Moss B. Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader. J Mol Biol. 1989 Mar 20;206(2):333–348. doi: 10.1016/0022-2836(89)90483-x. [DOI] [PubMed] [Google Scholar]
  16. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Funkhouser A. W., Purcell R. H., D'Hondt E., Emerson S. U. Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells. J Virol. 1994 Jan;68(1):148–157. doi: 10.1128/jvi.68.1.148-157.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Glass M. J., Jia X. Y., Summers D. F. Identification of the hepatitis A virus internal ribosome entry site: in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region. Virology. 1993 Apr;193(2):842–852. doi: 10.1006/viro.1993.1193. [DOI] [PubMed] [Google Scholar]
  19. Graff J., Normann A., Feinstone S. M., Flehmig B. Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol. 1994 Jan;68(1):548–554. doi: 10.1128/jvi.68.1.548-554.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hellen C. U., Witherell G. W., Schmid M., Shin S. H., Pestova T. V., Gil A., Wimmer E. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7642–7646. doi: 10.1073/pnas.90.16.7642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Innis B. L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C. A., Suntayakorn S., Suknuntapong T., Safary A., Tang D. B. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994 May 4;271(17):1328–1334. [PubMed] [Google Scholar]
  22. Jang S. K., Kräusslich H. G., Nicklin M. J., Duke G. M., Palmenberg A. C., Wimmer E. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol. 1988 Aug;62(8):2636–2643. doi: 10.1128/jvi.62.8.2636-2643.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jang S. K., Wimmer E. Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev. 1990 Sep;4(9):1560–1572. doi: 10.1101/gad.4.9.1560. [DOI] [PubMed] [Google Scholar]
  24. Jansen R. W., Newbold J. E., Lemon S. M. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology. 1988 Apr;163(2):299–307. doi: 10.1016/0042-6822(88)90270-x. [DOI] [PubMed] [Google Scholar]
  25. Karron R. A., Daemer R., Ticehurst J., D'Hondt E., Popper H., Mihalik K., Phillips J., Feinstone S., Purcell R. H. Studies of prototype live hepatitis A virus vaccines in primate models. J Infect Dis. 1988 Feb;157(2):338–345. doi: 10.1093/infdis/157.2.338. [DOI] [PubMed] [Google Scholar]
  26. Kozak M. The scanning model for translation: an update. J Cell Biol. 1989 Feb;108(2):229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lemon S. M. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985 Oct 24;313(17):1059–1067. doi: 10.1056/NEJM198510243131706. [DOI] [PubMed] [Google Scholar]
  28. Meerovitch K., Pelletier J., Sonenberg N. A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation. Genes Dev. 1989 Jul;3(7):1026–1034. doi: 10.1101/gad.3.7.1026. [DOI] [PubMed] [Google Scholar]
  29. Meerovitch K., Svitkin Y. V., Lee H. S., Lejbkowicz F., Kenan D. J., Chan E. K., Agol V. I., Keene J. D., Sonenberg N. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol. 1993 Jul;67(7):3798–3807. doi: 10.1128/jvi.67.7.3798-3807.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Midthun K., Ellerbeck E., Gershman K., Calandra G., Krah D., McCaughtry M., Nalin D., Provost P. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. J Infect Dis. 1991 Apr;163(4):735–739. doi: 10.1093/infdis/163.4.735. [DOI] [PubMed] [Google Scholar]
  31. Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90. [PMC free article] [PubMed] [Google Scholar]
  32. Pelletier J., Kaplan G., Racaniello V. R., Sonenberg N. Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol. 1988 Jul;62(7):2219–2227. doi: 10.1128/jvi.62.7.2219-2227.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pelletier J., Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 1988 Jul 28;334(6180):320–325. doi: 10.1038/334320a0. [DOI] [PubMed] [Google Scholar]
  34. Provost P. J., Hilleman M. R. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med. 1979 Feb;160(2):213–221. doi: 10.3181/00379727-160-40422. [DOI] [PubMed] [Google Scholar]
  35. Ross B. C., Anderson B. N., Edwards P. C., Gust I. D. Nucleotide sequence of high-passage hepatitis A virus strain HM175: comparison with wild-type and cell culture-adapted strains. J Gen Virol. 1989 Oct;70(Pt 10):2805–2810. doi: 10.1099/0022-1317-70-10-2805. [DOI] [PubMed] [Google Scholar]
  36. Shaffer D. R., Brown E. A., Lemon S. M. Large deletion mutations involving the first pyrimidine-rich tract of the 5' nontranslated RNA of human hepatitis A virus define two adjacent domains associated with distinct replication phenotypes. J Virol. 1994 Sep;68(9):5568–5578. doi: 10.1128/jvi.68.9.5568-5578.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shaffer D. R., Lemon S. M. Temperature-sensitive hepatitis A virus mutants with deletions downstream of the first pyrimidine-rich tract of the 5' nontranslated RNA are impaired in RNA synthesis. J Virol. 1995 Oct;69(10):6498–6506. doi: 10.1128/jvi.69.10.6498-6506.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Siegl G., Lemon S. M. Recent advances in hepatitis A vaccine development. Virus Res. 1990 Oct;17(2):75–92. doi: 10.1016/0168-1702(90)90070-r. [DOI] [PubMed] [Google Scholar]
  39. Sjogren M. H., Purcell R. H., McKee K., Binn L., Macarthy P., Ticehurst J., Feinstone S., Caudill J., See A., Hoke C. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Vaccine. 1992;10 (Suppl 1):S135–S137. doi: 10.1016/0264-410x(92)90568-5. [DOI] [PubMed] [Google Scholar]
  40. Taylor K. L., Murphy P. C., Asher L. V., LeDuc J. W., Lemon S. M. Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175/p16) in susceptible New World owl monkeys. J Infect Dis. 1993 Sep;168(3):592–601. doi: 10.1093/infdis/168.3.592. [DOI] [PubMed] [Google Scholar]
  41. Werzberger A., Mensch B., Kuter B., Brown L., Lewis J., Sitrin R., Miller W., Shouval D., Wiens B., Calandra G. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med. 1992 Aug 13;327(7):453–457. doi: 10.1056/NEJM199208133270702. [DOI] [PubMed] [Google Scholar]
  42. Whetter L. E., Day S. P., Elroy-Stein O., Brown E. A., Lemon S. M. Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol. 1994 Aug;68(8):5253–5263. doi: 10.1128/jvi.68.8.5253-5263.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES